CVE-2025-68347
Multiple vulnerabilities have been discovered in IBM products. Some of them allow an attacker to cause remote arbitrary code execution, privilege escalation and remote denial of service.
CSIRTS triage
- What
- Multiple vulnerabilities across IBM products allow remote code execution, privilege escalation, and denial of service.
- Who is affected
- IBM product customers across multiple product lines are affected.
- Urgency
- High urgency; RCE and privilege escalation vectors present significant risk.
- Action
- Check IBM security advisories for specific product affected versions and apply patches accordingly.
AI-assisted analysis generated from the source advisory — verify against the original.
⚡ Watch CVE-2025-68347
Get an email if CVE-2025-68347 is added to CISA KEV, gains public exploit code, or a new advisory cites it — max one per day, one-click unsubscribe.
Exploitation outlook
- Low exploitation risk0.15% 30-day exploitation probability — currently an unlikely target, but scores change as exploit code circulates. Riskier than 5% of all EPSS-scored CVEs.
Advisory coverage (1)
- unknownMultiple vulnerabilities in IBM products (August 07, 2026)cert-fr-avis · 2026-08-07
External references
Embed the live status
— this badge updates automatically when the KEV or exploit status changes. How to embed it →
[](https://www.csirts.com/cve/CVE-2025-68347)